Sit Investment Associates Inc Gilead Sciences, Inc. Transaction History

Sit Investment Associates Inc

$4.48 Billion
Q3 2024

A detailed history of Sit Investment Associates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sit Investment Associates Inc holds 14,940 shares of GILD stock, worth $1.34 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

14,940

Previous 19,715 24.22%

Holding current value

$1.34 Million

Previous $1.35 Million 7.39%

% of portfolio

0.03%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $317,967 - $401,052	-4,775 Reduced 24.22%	14,940 $1.25 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $10.6 Million - $12.2 Million	-167,455 Reduced 89.47%	19,715 $1.35 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $1.06 Million - $1.29 Million	-14,790 Reduced 7.32%	187,170 $13.7 Million
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $2.88 Million - $3.26 Million	39,260 Added 24.13%	201,960 $16.4 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $2.27 Million - $2.47 Million	30,640 Added 23.2%	162,700 $12.2 Million
Q2 2023 Aug 10, 2023	BUY	$76.01 - $86.7 $476,582 - $543,609	6,270 Added 4.98%	132,060 $10.2 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $3.51 Million - $4 Million	45,365 Added 56.41%	125,790 $10.4 Million
Q4 2022 Feb 10, 2023	BUY	$62.32 - $89.47 $5.01 Million - $7.2 Million	80,425 New	80,425 $6.9 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $369,816 - $419,748	-5,700 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $181,280 - $206,560	-3,200 Reduced 35.96%	5,700 $332,000
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $392,040 - $434,060	-5,500 Reduced 38.19%	8,900 $687,000
Q2 2018 Jul 19, 2018	SELL	$64.88 - $75.68 $19.5 Million - $22.8 Million	-301,120 Reduced 95.44%	14,400 $1.02 Million
Q1 2018 Apr 20, 2018	BUY	$72.84 - $88.8 $3.18 Million - $3.88 Million	43,660 Added 16.06%	315,520 $23.8 Million
Q4 2017 Jan 10, 2018	BUY	$71.15 - $83.52 $15.2 Million - $17.8 Million	213,710 Added 367.52%	271,860 $19.5 Million
Q3 2017 Oct 18, 2017	BUY	$72.11 - $85.47 $4.19 Million - $4.97 Million	58,150	58,150 $4.71 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sit Investment Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sit Investment Associates Inc with notifications on news.

Account

Sit Investment Associates Inc Gilead Sciences, Inc. Transaction History